miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting
miR-182启动子高甲基化可预测真实世界中接受AZA+VEN治疗的AML患者的更佳预后
期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-025-01823-1
Xu, Yilan; Li, Danyang; Wang, Na; Ge, Bei; Meng, Chen; Zhao, Min; Lin, Zihan; Li, Min; Yuan, Yigang; Cai, Yue; Shi, Liuzhi; Gao, Shenmeng; Ye, Haige